{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:51:03Z","timestamp":1789509063515,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Education and Science of the Republic of Serbia"},{"name":"Provincial Secretariat for Higher Education and Scientific Research of Vojvodina"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biopha.2017.03.045","type":"journal-article","created":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T02:02:29Z","timestamp":1490752949000},"page":"216-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Insight into anti-diabetic effect of low dose of stevioside"],"prefix":"10.1016","volume":"90","author":[{"given":"Vladimirka","family":"Ili\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u0161a","family":"Vukmirovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neboj\u0161a","family":"Stilinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"\u010capo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Arsenovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Milija\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2017.03.045_bib0005","first-page":"267","article-title":"Stevia rebaudiana (Bert.) Bertoni \u2014a review","volume":"1","author":"Madan","year":"2010","journal-title":"Indian J. Nat. Prod. Resour."},{"issue":"1","key":"10.1016\/j.biopha.2017.03.045_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pharmthera.2008.09.007","article-title":"Therapeutic benefits beyond sweetness","volume":"121","author":"Chatsudthipong","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2017.03.045_bib0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0031-9422(03)00426-6","article-title":"Stevioside","volume":"64","author":"Geuns","year":"2003","journal-title":"Phytochemistry"},{"issue":"11\u201312","key":"10.1016\/j.biopha.2017.03.045_bib0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.nut.2013.03.024","article-title":"Non-nutritive sweeteners: review and update","volume":"29","author":"Shankar","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2017.03.045_bib0025","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.lfs.2009.02.026","article-title":"Oxidative stress and metabolic syndrome","volume":"84","author":"Roberts","year":"2009","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14336\/AD.2014.0305","article-title":"Metabolic syndrome, aging and involvement of oxidative stress","volume":"6","author":"Bonomini","year":"2015","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2017.03.045_bib0035","unstructured":"International Diabetes Federation, Diabetes Atlas (2015), Seventh Edition. http:\/\/www.diabetesatlas.org\/ (Accessed 04.10.2016.)"},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0040","first-page":"367","article-title":"Effect of Laurus nobilis L. esential oil and its main components of \u03b1-glucosidase and reactive oxygen species scavenging activity","volume":"12","author":"Basak","year":"2013","journal-title":"Iran J. Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.03.045_bib0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2125.2000.00260.x","article-title":"A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension","volume":"50","author":"Chan","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2017.03.045_bib0050","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.2903\/j.efsa.2015.4316","article-title":"Scientific opinion on the safety of the proposed amendment of the specifications for steviol glycosides (E 960) as a food additive","volume":"13","author":"EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to food)","year":"2015","journal-title":"EFSA J."},{"key":"10.1016\/j.biopha.2017.03.045_bib0055","unstructured":"Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Guidance for Industry \u2013 Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. 2005."},{"issue":"10","key":"10.1016\/j.biopha.2017.03.045_bib0060","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/ptr.3182","article-title":"Pharmacodynamic action of a commercial preparation of the mushroom Coprinus comatus in rats","volume":"24","author":"Sabo","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2017.03.045_bib0065","series-title":"Practical Methods in Electron Microscopy","first-page":"48","article-title":"Quantitative methods in biology","author":"Williams","year":"1977"},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdiacomp.2012.10.001","article-title":"Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana","volume":"27","author":"Shivanna","year":"2013","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.biopha.2017.03.045_bib0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21608\/ejhm.2005.18102","article-title":"Stevioside is a low caloric sweetner to milky drink and its protective role against oxidative stress in diabetic rats","volume":"20","author":"Badawi","year":"2005","journal-title":"Egypt. J. Hosp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.03.045_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/meta.2003.50058","article-title":"Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat","volume":"52","author":"Jeppesen","year":"2003","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.biopha.2017.03.045_bib0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2298\/VSP120524014V","article-title":"Effect of aqueous solution of stevioside on pharmacological properties of some cardioactive drugs","volume":"71","author":"Vasovi\u0107","year":"2014","journal-title":"Vojnosanit. Pregl."},{"issue":"11","key":"10.1016\/j.biopha.2017.03.045_bib0090","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1248\/bpb.25.1488","article-title":"Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin","volume":"25","author":"Yusukawa","year":"2002","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2017.03.045_bib0095","first-page":"689","article-title":"Stevia rebaudiana Bertoni: a review","volume":"1","author":"Mishra","year":"2012","journal-title":"Global J. Pharm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.03.045_bib0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/0974-8490.69128","article-title":"Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats","volume":"2","author":"Kujur","year":"2010","journal-title":"Pharmacogn. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.03.045_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.17305\/bjbms.2011.2616","article-title":"Hypoglycemic action of stevioside and a barley and brewers yeast based preparation in the experimental model on mice","volume":"11","author":"Ceki\u0107","year":"2011","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2017.03.045_bib0110","doi-asserted-by":"crossref","first-page":"348169","DOI":"10.1155\/2013\/348169","article-title":"Steviol glycosides modulate glucose transport in different cell types","volume":"2013","author":"Rizzo","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2017.03.045_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.biomag.2012.07.001","article-title":"Study of effect of Stevia rebaudiana bertoni on oxidative stress in type 3 diabetic rat models","volume":"2","author":"Sharma","year":"2012","journal-title":"Biomed. Aging Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0975-7406.80779","article-title":"Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) an alloxan-induced diabetic rats","volume":"3","author":"Misra","year":"2011","journal-title":"J. Pharm. Bioallied Sci."},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0125","first-page":"75","article-title":"Farmakolo\u0161ki efekti komercijalnih preparata, Stevia rebaudiana\u2013Bertoni","volume":"39","author":"Ra\u0161kovi\u0107","year":"2003","journal-title":"Iugosl. Physiol. Pharmacol. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2017.03.045_bib0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1900\/RDS.2006.3.189","article-title":"Can stevioside in combination with a soy-based dietary supplement be a new useful treatment of type 2 diabetes? An in vivo study in the diabetic Goto-Kakizaki rat","volume":"3","author":"Jeppesen","year":"2006","journal-title":"Rev. Diabet. Stud."},{"key":"10.1016\/j.biopha.2017.03.045_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.appet.2010.03.009","article-title":"Effects of stevia, aspartame, and sucrose on food intake satiety, and postprandial glucose and insulin levels","volume":"55","author":"Anton","year":"2010","journal-title":"Appetite"},{"issue":"2","key":"10.1016\/j.biopha.2017.03.045_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0026-0495(00)91325-8","article-title":"Stevioside acts directly on pancreatic \u03b2 cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity","volume":"149","author":"Jeppesen","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2017.03.045_bib0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","article-title":"The mechanisms of alloxan- and streptozotocin-induced diabetes","volume":"51","author":"Lenzen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2017.03.045_bib0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ijo.2009.261","article-title":"Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice","volume":"34","author":"Geeraert","year":"2010","journal-title":"Int. J. Obes."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216329638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216329638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:16:19Z","timestamp":1658880979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216329638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":30,"alternative-id":["S0753332216329638"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.03.045","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insight into anti-diabetic effect of low dose of stevioside","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}